,,iv #aae? ,,congress #a/ ,session ,h4 ,,res4 #bje ,,9 ,,! ,,h\se ,,( ,,repres5tatives ,m>* #af1 #bjag ,mrs4 ,davis ( ,cali=nia submitt$ ! foll[+ resolution2 :i* 0 ref]r$ to ! ,committee on ,en]gy & ,comm]ce ,,resolution ,express+ ! s5se ( ! ,h\se ( ,repres5tatives ) respect to ensur+ t wom5's heal? c>e "u curr5t law is pres]v$4 ,:]eas1 9 #bjjf1 #a 9 #e wom5 ( *ildbe>+ age lack$ heal? insurance cov]age1 a rate exce$+ t = all ,am]icans "u age #fe2 ,:]eas1 9 #bjjh1 only #ab p]c5t ( heal? insurance plans on ! individual m>ket cov]$ mat]nity c>e2 ,:]eas1 9 #bjji1 ne>ly "o-?ird ( wom5 report$ t !y ei!r lack$ heal? insurance cov]age or 7 9 transition betwe5 types ( cov]age ar\nd ! "t ( pregnancy2 ,:]eas un9sur$ pregnant wom5 are less likely to seek pr5atal c>e dur+ ! fir/ trime/] or receive ! optimal numb] ( visits dur+ _! pregnancy1 & h a #ca p]c5t high] likelihood ( exp]i5c+ an adv]se heal? outcome aft] giv+ bir?2 ,:]eas inadequate use ( pr5atal c>e is associat$ ) increas$ risks ( l[ bir? weight infants1 pret]m bir?s1 neonatal mortality1 infant mortality1 & mat]nal mortality2 ,:]eas e #a sp5t on pr5atal c>e saves #c4ch1 prim>ily 9 r$uc$ sp5d+ = l[ bir? weight & pret]m infants2 ,:]eas1 prior to ! enactm5t ( curr5t law1 a #be-ye>-old woman c\ld pay z mu* z #ha p]c5t m ?an a man = id5tical heal? insurance cov]age1 a practice t co/ wom5 approximately #a billion annually2 ,:]eas un9sur$ wom5 ) brea/ canc] are #cj to #ej p]c5t m likely to die f ! disease2 ,:]eas un9sur$ noneld]ly wom5 are ?ree times less likely to h _h a ,pap te/ )9 ! la/ ?ree ye>s1 ) a #fj p]c5t great] risk ( a late-/age c]vical canc] diagnosis2 ,:]eas m ?an #ee million wom5 ) private heal? insurance curr5tly h access to cov]age ) no co/ %>+ ( evid5ce-bas$ prev5tive s]vices1 includ+ brea/ & c]vical canc] scre5+1 brea/fe$+ s]vices & supplies1 contraception & contraceptive c\nsel+1 scre5+ = int]p]sonal & dome/ic viol5ce1 c\nsel+ = sexually transmitt$ infections1 scre5+ = human immunodefici5cy virus infection1 scre5+ = ge/ational diabetes1 & well-woman prev5tive visits2 ,:]eas1 aft] ! enactm5t ( curr5t law1 wom5 sav$ #a4d billion on out-(-pocket co/s = contraceptives 9 j "o ye>2 ,:]eas wom5 9 all #ej ,/ates & ! ,unit$ ,/ates t]ritories no long] ne$ a ref]ral to see _! ob-gyn provid]2 ,:]eas r\ghly #fe million wom5 ) pre-exi/+ conditions1 includ+ a prior ,ces>ean section or a hi/ory ( dome/ic viol5ce1 c no long] be d5i$ heal? insurance cov]age2 ,:]eas #ci4e million wom5 are no long] subject to lifetime cov]age limits t previ\sly left ^? ) s]i\s heal? conditions vuln]able to los+ heal? insurance cov]age mid-treatm5t2 & ,:]eas wom5 are no long] subject to wait+ p]iods rang+ f n9e mon?s to two ye>s = access to mat]nity c>e & o!r heal? c>e3 ,n[1 !re=e1 be x ,t x is ! s5se ( ! ,h\se ( ,repres5tatives t our ,nation's heal? c>e sy/em %\ld cont9ue to provide heal? insurance cov]age = fundam5tal elem5ts ( wom5's heal? c>e1 includ+-- 7#a7 cov]age = mat]nity c>e = all wom5 "u all heal? insurance plans2 7#b7 cov]age ) no co/ %>+ ( evid5ce-bas$ prev5tive c>e & s]vices1 includ+-- 7,a7 brea/ canc] scre5+ = av]age-risk wom52 7,b7 brea/fe$+ s]vices & supplies2 7,c7 scre5+ = c]vical canc]2 7,d7 contraception & contraceptive c\nsel+2 7,e7 scre5+ = ge/ational diabetes2 7,f7 scre5+ = human immunodefici5cy virus2 7,g7 scre5+ = int]p]sonal & dome/ic viol5ce2 7,h7 c\nsel+ = sexually transmitt$ infections2 & 7,i7 well-woman prev5tive visits2 7#c7 direct access to ob-gyn c>e2 7#d7 prohibition aga9/ pre-exi/+ condition exclusions2 7#e7 no g5d] rat+2 7#f7 no annual or lifetime limits or rescissions2 & 7#g7 no excessive wait+ p]iods = access to heal? c>e4